NCT00305799: Hearing Loss and Dizziness in Patients Receiving Oxaliplatin for Solid Tumors |
|
|
| Completed | N/A | 59 | US | management of therapy complications | Case Comprehensive Cancer Center, National Cancer Institute (NCI) | Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific | 12/12 | 11/14 | | |
